Safety study of GM-2505 in Depression
This study is recruiting in the United Kingdom. It is testing GM-2505 for Depression.
In Manchester
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It is testing GM-2505 for Depression.
In ManchesterThis study is recruiting in the United States. It focuses on depression.
Multiple locations, including GilbertThis study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting in Uganda. It focuses on Anxiety.
In UgandaThis study is recruiting in the United Kingdom. It focuses on anxiety.
In United KingdomThis study is recruiting in Sri Lanka. It focuses on depression.
In RagamaThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in Kuwait. It is testing impact of Breath Awareness Using Pyramid on Symptoms of Anxiety and Depression for depression.
In Kuwait CityThis study is recruiting in South Korea. It focuses on Depression.
In South KoreaThis study is recruiting in Singapore. It focuses on depression.
In SingaporeThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Anxiety.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.